156 related articles for article (PubMed ID: 26567955)
1. Metastatic cardiac tumor from urothelial carcinoma detected by transthoracic echocardiography: a case report.
Nakashima Y; Tanioka K; Kubo T; Yamasaki N; Yamasaki I; Syuin T; Kitaoka H
J Med Case Rep; 2015 Nov; 9():257. PubMed ID: 26567955
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of metastatic urothelial carcinoma arising in a transplanted renal allograft with paclitaxel, cisplatin, and gemcitabine combination therapy: a case report.
Kojima Y; Takahi Y; Ichimaru N; Okumi M; Takahara S; Nonomura N
BMC Res Notes; 2015 Feb; 8():25. PubMed ID: 25648269
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy with gemcitabine, paclitaxel, and cisplatin in the treatment of patients with advanced transitional cell carcinoma of the urothelium.
Ecke TH; Bartel P; Koch S; Ruttloff J; Theissig F
Oncol Rep; 2006 Dec; 16(6):1381-8. PubMed ID: 17089065
[TBL] [Abstract][Full Text] [Related]
4. Palliative chemotherapy with gemcitabine, paclitaxel, and cisplatin as first-line treatment following gemcitabine monotherapy for patients with transitional cell carcinoma of the urothelium.
Ecke TH; Gerullis H; Bartel P; Koch S; Ruttloff J
Minerva Urol Nefrol; 2009 Mar; 61(1):1-8. PubMed ID: 19417721
[TBL] [Abstract][Full Text] [Related]
5. Fatal acute cardiac vasculopathy during cisplatin-gemcitabine-bevacizumab (CGB) chemotherapy for advanced urothelial carcinoma.
Gruenberg J; Manivel JC; Gupta P; Dykoski R; Mesa H
J Infect Chemother; 2016 Feb; 22(2):112-6. PubMed ID: 26423690
[TBL] [Abstract][Full Text] [Related]
6. Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987.
Bellmunt J; von der Maase H; Mead GM; Skoneczna I; De Santis M; Daugaard G; Boehle A; Chevreau C; Paz-Ares L; Laufman LR; Winquist E; Raghavan D; Marreaud S; Collette S; Sylvester R; de Wit R
J Clin Oncol; 2012 Apr; 30(10):1107-13. PubMed ID: 22370319
[TBL] [Abstract][Full Text] [Related]
7. [Treatment and prognosis of 117 patients with advanced urothelial carcinoma of the bladder].
Song Y; Yang L; Zhou A; Chi Y; Wang J
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):212-6. PubMed ID: 24785283
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic agents, chemotherapy, and the treatment of metastatic transitional cell carcinoma.
Vogelzang NJ
J Clin Oncol; 2013 Feb; 31(6):670-5. PubMed ID: 23341524
[TBL] [Abstract][Full Text] [Related]
9. Successful management of metastatic urothelial carcinoma with gemcitabine and Paclitaxel chemotherapy in a hemodialysis patient.
Ide H; Satou A; Hoshino K; Yasumizu Y; Uchida Y; Tasaka Y; Masuda T
Urol Int; 2011; 87(2):245-7. PubMed ID: 21709400
[TBL] [Abstract][Full Text] [Related]
10. A rare case of successfully treated cardiac metastasis from transitional cell bladder cancer.
Doshi TV; Doshi JV; Makaryus JN; Makaryus AN
Am J Ther; 2013; 20(3):307-10. PubMed ID: 21436764
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine.
Bellmunt J; Albanell J; Paz-Ares L; Climent MA; González-Larriba JL; Carles J; de la Cruz JJ; Guillem V; Díaz-Rubio E; Cortés-Funes H; Baselga J;
Cancer; 2002 Aug; 95(4):751-7. PubMed ID: 12209718
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium.
Hainsworth JD; Meluch AA; Litchy S; Schnell FM; Bearden JD; Yost K; Greco FA
Cancer; 2005 Jun; 103(11):2298-303. PubMed ID: 15856431
[TBL] [Abstract][Full Text] [Related]
13. [Pathological complete response to gemcitabine and cisplatin chemotherapy for advanced upper tract urothelial carcinoma: a case report].
Matsuki M; Takahashi A; Katou S; Takayanagi A; Takagi Y; Kamata K
Nihon Hinyokika Gakkai Zasshi; 2013 Jan; 104(1):33-7. PubMed ID: 23457933
[TBL] [Abstract][Full Text] [Related]
14. Second-line systemic therapies for metastatic urothelial carcinoma: a population-based cohort analysis.
Tsang ES; Forbes C; Chi KN; Eigl BJ; Parimi S
Curr Oncol; 2019 Apr; 26(2):e260-e265. PubMed ID: 31043835
[TBL] [Abstract][Full Text] [Related]
15. Second Line Chemotherapy for Advanced and Metastatic Urothelial Carcinoma: Vinflunine and Beyond-A Comprehensive Review of the Current Literature.
Oing C; Rink M; Oechsle K; Seidel C; von Amsberg G; Bokemeyer C
J Urol; 2016 Feb; 195(2):254-63. PubMed ID: 26410730
[TBL] [Abstract][Full Text] [Related]
16. Systemic therapy for unresectable and metastatic transitional cell carcinoma of the urothelium: first-line and beyond.
Cheng T
Curr Opin Support Palliat Care; 2008 Sep; 2(3):153-60. PubMed ID: 18685414
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of paclitaxel and carboplatin as second-line chemotherapy for advanced urothelial carcinoma resistant to first-line therapy with gemcitabine and cisplatin.
Terakawa T; Miyake H; Yokoyama N; Miyazaki A; Tanaka H; Inoue T; Fujisawa M
Urol Int; 2014; 92(2):180-5. PubMed ID: 24246751
[TBL] [Abstract][Full Text] [Related]
18. Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review.
Cho MH; Kim SH; Park WS; Joung JY; Seo HK; Chung J; Lee KH
World J Surg Oncol; 2016 Oct; 14(1):270. PubMed ID: 27765044
[TBL] [Abstract][Full Text] [Related]
19. Biweekly paclitaxel and gemcitabine for patients with advanced urothelial cancer ineligible for cisplatin-based regimen.
Takahashi T; Higashi S; Nishiyama H; Segawa T; Nakamura E; Kinoshita H; Itoh N; Yamamoto S; Kamoto T; Habuchi T; Ogawa O
Jpn J Clin Oncol; 2006 Feb; 36(2):104-8. PubMed ID: 16418182
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: a phase II trial of the Minnie pearl cancer research network.
Meluch AA; Greco FA; Burris HA; O'Rourke T; Ortega G; Steis RG; Morrissey LH; Johnson V; Hainsworth JD
J Clin Oncol; 2001 Jun; 19(12):3018-24. PubMed ID: 11408496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
